Covid-19

Isabella S Glenn1, Lauren N Hall1, Mir M Khalid2,3

  • 1Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, California 94143, United States.

PubMed
概括

候选药物中的体聚合可以在COVID-19抗病毒试验中引起假阳性. 减少聚合的治疗方法显著降低了药物的有效性,揭示了聚合是药物重用中的常见工件.